Victory Capital Management Inc. Has $7.84 Million Holdings in UFP Technologies, Inc. (NASDAQ:UFPT)

Victory Capital Management Inc. trimmed its position in shares of UFP Technologies, Inc. (NASDAQ:UFPT) by 27.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 32,058 shares of the industrial products company’s stock after selling 12,133 shares during the quarter. Victory Capital Management Inc. owned approximately 0.42% of UFP Technologies worth $7,839,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently added to or reduced their stakes in the company. Wasatch Advisors LP boosted its stake in shares of UFP Technologies by 65.4% during the 3rd quarter. Wasatch Advisors LP now owns 420,549 shares of the industrial products company’s stock worth $133,188,000 after acquiring an additional 166,262 shares in the last quarter. State Street Corp boosted its position in UFP Technologies by 1.4% during the third quarter. State Street Corp now owns 283,460 shares of the industrial products company’s stock worth $89,772,000 after purchasing an additional 4,007 shares during the period. Congress Asset Management Co. grew its holdings in UFP Technologies by 14.2% during the fourth quarter. Congress Asset Management Co. now owns 281,325 shares of the industrial products company’s stock valued at $68,787,000 after purchasing an additional 35,022 shares during the last quarter. Geode Capital Management LLC raised its position in shares of UFP Technologies by 2.0% in the third quarter. Geode Capital Management LLC now owns 172,996 shares of the industrial products company’s stock valued at $54,799,000 after purchasing an additional 3,333 shares during the period. Finally, Boston Trust Walden Corp acquired a new stake in shares of UFP Technologies in the fourth quarter worth $26,395,000. Institutional investors and hedge funds own 87.28% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com lowered shares of UFP Technologies from a “hold” rating to a “sell” rating in a research note on Thursday, January 23rd.

Insider Transactions at UFP Technologies

In other UFP Technologies news, Director Daniel C. Croteau sold 6,846 shares of UFP Technologies stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $228.41, for a total transaction of $1,563,694.86. Following the sale, the director now owns 1,785 shares in the company, valued at $407,711.85. The trade was a 79.32 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 6.17% of the company’s stock.

UFP Technologies Stock Performance

UFPT opened at $210.70 on Friday. The company has a quick ratio of 1.43, a current ratio of 2.57 and a debt-to-equity ratio of 0.64. The stock’s 50 day moving average price is $250.44 and its two-hundred day moving average price is $282.36. The firm has a market capitalization of $1.62 billion, a P/E ratio of 30.06 and a beta of 1.15. UFP Technologies, Inc. has a 12-month low of $188.50 and a 12-month high of $366.41.

UFP Technologies (NASDAQ:UFPT) last announced its earnings results on Tuesday, February 25th. The industrial products company reported $2.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.01 by $0.45. UFP Technologies had a net margin of 11.74% and a return on equity of 18.92%. The business had revenue of $144.07 million for the quarter, compared to analyst estimates of $141.67 million.

UFP Technologies Profile

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.